Therapeutics

The International Journal of Coronaviruses is a platform that publishes peer-reviewed research articles related to all aspects of coronaviruses, including diagnostics, immunology, therapeutics, and clinical management. One of the crucial areas of research for coronavirus-related diseases is the development of effective therapeutics to combat the deadly virus. Therapeutics refer to the treatments used to manage or cure diseases. In the context of coronavirus, therapeutics include antiviral drugs, immunomodulators, and monoclonal antibodies. The goal of coronavirus therapeutics is to reduce the spread of the virus, minimize symptoms, and prevent complications. Since the emergence of the COVID-19 pandemic, the world has seen an unprecedented effort to develop effective therapeutics to combat the virus. Some of the most promising therapeutics include remdesivir, dexamethasone, and convalescent plasma therapy. Remdesivir has been shown to reduce the duration of hospitalization for COVID-19 patients, while dexamethasone has been shown to reduce mortality rates. Convalescent plasma therapy, on the other hand, involves using blood plasma from recovered COVID-19 patients to treat severely ill patients. Research into therapeutics is ongoing and is expected to yield more effective treatments for the coronaviruses. The International Journal of Coronaviruses plays a crucial role in disseminating the latest research findings in therapeutics for coronavirus to researchers, healthcare professionals, and policymakers worldwide. The journal provides a platform for researchers to present their work, exchange ideas, and contribute towards the fight against the COVID-19 pandemic.